NCT00616291View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine

Trial Locations (1)

77030

Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Baylor College of Medicine

OTHER

NCT00616291 - Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer | Biotech Hunter | Biotech Hunter